olmesartan has been researched along with 4-[3-(1H-imidazol-5-yl)propyl]piperidine in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (4-[3-(1H-imidazol-5-yl)propyl]piperidine) | Trials (4-[3-(1H-imidazol-5-yl)propyl]piperidine) | Recent Studies (post-2010) (4-[3-(1H-imidazol-5-yl)propyl]piperidine) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 5 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, EA; Dosa, PI | 1 |
1 review(s) available for olmesartan and 4-[3-(1H-imidazol-5-yl)propyl]piperidine
| Article | Year |
|---|---|
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
Topics: Animals; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2016 |